COMMUNIQUÉS West-GlobeNewswire

-
AB Science annonce les résultats de l’analyse intérimaire de l’étude AB09004 dans la maladie d’Alzheimer
26/06/2019 -
Protech Home Medical Obtains Default Judgment Against Fraudster
26/06/2019 -
OSE Immunotherapeutics Announces Results of 2019 Annual Shareholder Meeting
26/06/2019 -
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
26/06/2019 -
Ronald McDonald House Charities Named Title Partner of the 2019 Triple-A All-Star Game
26/06/2019 -
HydraFacial MD® Now Available with Dr. Samuel Hahn
26/06/2019 -
OmniSeq Board Names Margot Schoenborn to Succeed Mark Gardner as CEO
26/06/2019 -
LifePod Announces Early Access to First Proactive-Voice Virtual Caregiver Service for Older Adults and Chronic Care Patients at Home
26/06/2019 -
Copeland Biosciences Corp. Retains KCSA Strategic Communications as Corporate Communications Counsel
26/06/2019 -
Fagron NV: Fagron reaches settlement in principle with US Department of Justice
26/06/2019 -
BioPorto Appoints New Chief Medical Officer
26/06/2019 -
Generex Biotechnology Subsidiary Olaregen Therapeutix Receives American Podiatry Medical Associations “Seal of Approval” for Excellagen Wound Conforming Matrix
26/06/2019 -
Y-mAbs Announces Data to be Presented at 2019 SIOP
26/06/2019 -
Golden Leaf Holdings Ltd. Announces Election of New Board of Directors, Approval of Amendment to Terms of Debenture Indenture for Debentures Maturing November 2, 2019 and Release of Slide Presentation
26/06/2019 -
Global Blood Therapeutics Prices a $200.0 Million Common Stock Public Offering
26/06/2019 -
Driven Deliveries Inc. Announces Partnership with Cypress Hill Rapper, B-Real’s, Dr. Greenthumb’s Dispensary
26/06/2019 -
Ziopharm Oncology Completes Enrollment of Controlled IL-12 plus Opdivo® (nivolumab) Phase 1 Combination Trial in Brain Cancer
26/06/2019 -
Letter to Shareholders from Curt Fairbrother, CEO
26/06/2019 -
CorMedix Inc. Set to Join the Russell 2000® Index
26/06/2019
Pages